Perioperative Therapy for Muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Perioperative Therapy for Muscle Invasive Bladder Cancer

Published:2015-04 Issue:2 Volume:29 Page:301-318
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Leow Jeffrey J.,Fay André P.,Mullane Stephanie A.,Bellmunt Joaquim

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference84 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

3. Defining optimal therapy for muscle invasive bladder cancer;Herr;J Urol,2007

4. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data;Vale;Eur Urol,2005

5. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides;Reardon;Eur Urol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing risk of lymph node invasion in complete responders to neoadjuvant chemotherapy for muscle‐invasive bladder cancer;BJU International;2024-06-24

2. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-01

3. Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy;Urologic Oncology: Seminars and Original Investigations;2023-01

4. Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments;Frontiers in Oncology;2022-07-22

5. Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?;European Urology Oncology;2019-09